| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVEXIS INC COM | 1,028,763 | 49,103,000 | 18.99% | ||
| 2 | CLOVIS ONCOLOGY INC | 850,000 | 37,757,000 | 14.60% | ||
| 3 | MEDICINES CO | 828,198 | 28,109,000 | 10.87% | ||
| 4 | BEIGENE LTD | 850,000 | 25,806,000 | 9.98% | ||
| 5 | MEDICINES CO | 627,400 | 21,294,000 | 8.24% | Call | |
| 6 | BLUEPRINT MEDICINES CORP COM | 705,159 | 19,780,000 | 7.65% | ||
| 7 | Aquinox Pharmaceuticals Inc | 877,753 | 14,492,000 | 5.61% | ||
| 8 | INCYTE | 100,000 | 10,027,000 | 3.88% | ||
| 9 | ALNYLAM PHARMACEUTICALS INC | 250,000 | 9,360,000 | 3.62% | ||
| 10 | ALEXION PHARMACEUTIC | 75,000 | 9,176,000 | 3.55% | ||
| 11 | SEATTLE GENETICS INC | 100,000 | 5,277,000 | 2.04% | ||
| 12 | TESARO INC | 35,000 | 4,707,000 | 1.82% | ||
| 13 | MIRATI THERAPEUTICS INC COM | 757,935 | 3,600,000 | 1.39% | ||
| 14 | KURA ONCOLOGY INC | 533,251 | 3,146,000 | 1.22% | ||
| 15 | Strongbridge Biopharma plc | 940,000 | 2,256,000 | 0.87% | ||
| 16 | Sunesis Pharmaceuticals, Inc. | 525,000 | 1,901,000 | 0.74% | ||
| 17 | ARRAY BIOPHARMA INC COM | 200,000 | 1,758,000 | 0.68% | ||
| 18 | Syndax Pharmaceuticals Inc | 234,220 | 1,679,000 | 0.65% | ||
| 19 | EIGER BIOPHARMACEUTICALS INC | 138,331 | 1,612,000 | 0.62% | ||
| 20 | ALDEYRA THERAPEUTICS INC | 291,230 | 1,558,000 | 0.60% | ||
| 21 | Nabriva Therapeutics AG | 176,710 | 1,053,000 | 0.41% | ||
| 22 | ARADIGM CORP COM | 634,708 | 1,016,000 | 0.39% | ||
| 23 | AKARI THERAPEUTICS PLC | 139,899 | 985,000 | 0.38% | ||
| 24 | BELLEROPHON THERAPEUTICS INC | 1,857,143 | 966,000 | 0.37% | ||
| 25 | Onconova Therapeutics Inc | 316,380 | 718,000 | 0.28% | ||
| 26 | IGNYTA INC COM | 125,000 | 663,000 | 0.26% | ||
| 27 | NEXVET BIOPHARMA PUB LTD CO | 154,840 | 578,000 | 0.22% | ||
| 28 | ONCONOVA THERAPEUTICS INC | 241,644 | 150,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-002487, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
